Outcomes_NNS research_NN in_IN the_DT development_NN and_CC evaluation_NN of_IN practice_NN guidelines_NNS Abstract_NP |_SYM Background_NP |_SYM Practice_NN guidelines_NNS have_VBP been_VBN developed_VBN in_IN response_NN to_TO the_DT observation_NN that_IN variations_NNS exist_VBP in_IN clinical_JJ medicine_NN that_WDT are_VBP not_RB related_VBN to_TO variations_NNS in_IN the_DT clinical_JJ presentation_NN and_CC severity_NN of_IN the_DT disease_NN ._SENT Despite_IN their_PP$ widespread_JJ use_NN ,_, however_RB ,_, practice_NN guideline_NN evaluation_NN lacks_VBZ a_DT rigorous_JJ scientific_JJ methodology_NN to_TO support_VB its_PP$ development_NN and_CC application_NN ._SENT Discussion_NN |_SYM Firstly_RB ,_, we_PP review_VBP the_DT major_JJ epidemiological_JJ foundations_NNS of_IN practice_NN guideline_NN development_NN ._SENT Secondly_RB ,_, we_PP propose_VBP a_DT chronic_JJ disease_NN epidemiological_JJ model_NN in_IN which_WDT practice_NN patterns_NNS are_VBP viewed_VBN as_IN the_DT exposure_NN and_CC outcomes_NNS of_IN interest_NN such_JJ as_IN quality_NN or_CC cost_NN are_VBP viewed_VBN as_IN the_DT disease_NN ._SENT Sources_NNS of_IN selection_NN ,_, information_NN ,_, confounding_VBG and_CC temporal_JJ trend_NN bias_NN are_VBP identified_VBN and_CC discussed_VBN ._SENT Summary_NN |_SYM The_DT proposed_VBN methodological_JJ framework_NN for_IN outcomes_NNS research_NN to_TO evaluate_VB practice_NN guidelines_NNS reflects_VBZ the_DT selection_NN ,_, information_NN and_CC confounding_VBG biases_NNS inherent_JJ in_IN its_PP$ observational_JJ nature_NN which_WDT must_MD be_VB accounted_VBN for_IN in_IN both_CC the_DT design_NN and_CC the_DT analysis_NN phases_NNS of_IN any_DT outcomes_NNS research_NN study_NN ._SENT The_DT development_NN of_IN practice_NN guidelines_NNS |_SYM In_IN clinical_JJ medicine_NN ,_, variations_NNS exist_VBP that_DT do_VBP not_RB appear_VB to_TO be_VB related_VBN to_TO variations_NNS in_IN the_DT clinical_JJ presentation_NN and_CC severity_NN of_IN disease_NN ._SENT In_IN response_NN ,_, practice_NN guidelines_NNS have_VBP been_VBN developed_VBN in_IN an_DT attempt_NN to_TO reduce_VB the_DT wide_JJ practice_NN variations_NNS and_CC ,_, through_IN this_DT process_NN ,_, to_TO increase_VB the_DT appropriateness_NN and_CC quality_NN of_IN medical_JJ care_NN and_CC to_TO reduce_VB health_NN care_NN costs_NNS ._SENT Despite_IN the_DT publication_NN and_CC dissemination_NN of_IN practice_NN guidelines_NNS ,_, there_EX has_VBZ been_VBN relatively_RB little_JJ evaluation_NN of_IN the_DT application_NN and_CC impact_NN of_IN clinical_JJ practice_NN guidelines_NNS ._SENT Some_DT of_IN the_DT difficulty_NN in_IN the_DT evaluation_NN of_IN these_DT guidelines_NNS relates_VBZ to_TO the_DT methods_NNS that_WDT were_VBD used_VBN to_TO develop_VB them_PP ._SENT Guidelines_NNS have_VBP often_RB have_VB been_VBN developed_VBN before_IN adequate_JJ data_NNS have_VBP been_VBN available_JJ to_TO assess_VB the_DT relationship_NN between_IN clinical_JJ practice_NN patterns_NNS and_CC desired_VBN clinical_JJ outcomes_NNS ._SENT Nevertheless_RB ,_, there_EX have_VBP been_VBN some_DT reviews_NNS of_IN practice_NN guideline_NN evaluation_NN ._SENT While_IN epidemiological_JJ designs_NNS are_VBP commonly_RB used_VBN to_TO evaluate_VB the_DT effectiveness_NN of_IN health_NN care_NN interventions_NNS ,_, never_RB has_VBZ this_RB been_VBN discussed_VBN in_IN the_DT context_NN of_IN outcomes_NNS research_NN ._SENT We_PP propose_VBP the_DT use_NN of_IN a_DT methodological_JJ framework_NN for_IN outcomes_NNS research_NN to_TO evaluate_VB practice_NN guidelines_NNS ._SENT Methodological_JJ issues_NNS with_IN the_DT measurement_NN of_IN practice_NN variations_NNS |_SYM In_IN the_DT debate_NN about_IN reasons_NNS to_TO promote_VB the_DT development_NN of_IN practice_NN guidelines_NNS ,_, few_JJ have_VBP questioned_VBN whether_IN the_DT variations_NNS are_VBP real_JJ ,_, or_CC alternatively_RB ,_, whether_IN they_PP are_VBP simply_RB a_DT function_NN of_IN methodological_JJ flaws_NNS in_IN the_DT measurement_NN of_IN medical_JJ practices_NNS themselves_PP ,_, the_DT result_NN of_IN variations_NNS in_IN practice_NN patterns_NNS across_IN groups_NNS of_IN patients_NNS with_IN a_DT similar_JJ diagnosis_NN ,_, or_CC both_DT ._SENT Furthermore_RB ,_, few_JJ studies_NNS have_VBP addressed_VBN whether_IN practice_NN variations_NNS ,_, in_IN fact_NN ,_, lead_VB to_TO outcome_NN variations_NNS ._SENT Finally_RB ,_, little_JJ attention_NN has_VBZ been_VBN paid_VBN to_TO the_DT identification_NN and_CC measurement_NN of_IN initial_JJ conditions_NNS ,_, that_WDT is_VBZ ,_, the_DT potentially_RB confounding_VBG factors_NNS and_CC effect_NN modifiers_NNS of_IN the_DT practice_NN patterns_NNS outcomes_NNS relationship_NN ._SENT Measurement_NN of_IN practice_NN pattern_NN variation_NN |_SYM The_DT measurement_NN of_IN medical_JJ practice_NN patterns_NNS is_VBZ susceptible_JJ to_TO error_NN ._SENT Measurement_NN error_NN may_MD affect_VB the_DT validity_NN of_IN medical_JJ practice_NN measurement_NN in_IN three_CD major_JJ ways_NNS ._SENT First_RB ,_, it_PP may_MD lead_VB to_TO selection_NN bias_NN ,_, in_IN that_WDT subjects_NNS are_VBP selected_VBN to_TO belong_VB to_TO a_DT certain_JJ group_NN based_VBN on_IN an_DT erroneous_JJ diagnosis_NN ._SENT Secondly_RB ,_, it_PP may_MD lead_VB to_TO misclassification_NN of_IN exposure_NN (_( information_NN bias_NN )_) ,_, in_IN that_WDT patients_NNS treated_VBN with_IN a_DT specific_JJ practice_NN pattern_NN are_VBP classified_VBN in_IN the_DT wrong_JJ diagnostic_JJ group_NN ._SENT Thirdly_RB ,_, it_PP may_MD lead_VB to_TO misclassification_NN of_IN outcomes_NNS ,_, in_IN that_WDT patients_NNS with_IN a_DT given_VBN outcome_NN are_VBP classified_VBN in_IN the_DT wrong_JJ diagnostic_JJ group_NN ._SENT Potential_JJ problems_NNS with_IN the_DT measurement_NN of_IN practice_NN variations_NNS relate_VBP to_TO the_DT mechanisms_NNS that_WDT underlie_VBP the_DT choice_NN of_IN groups_NNS that_WDT are_VBP compared_VBN in_IN studies_NNS of_IN practice_NN variations_NNS ._SENT These_DT mechanisms_NNS must_MD be_VB defined_VBN clearly_RB to_TO minimize_VB selection_NN bias_NN ._SENT In_IN many_JJ studies_NNS of_IN practice_NN variations_NNS ,_, populations_NNS are_VBP arbitrarily_RB divided_VBN according_VBG to_TO hospitals_NNS ,_, regions_NNS ,_, counties_NNS ,_, or_CC countries_NNS ._SENT Little_JJ information_NN is_VBZ available_JJ about_IN the_DT factors_NNS that_WDT lead_VBP these_DT groups_NNS to_TO go_VB to_TO a_DT particular_JJ hospital_NN ,_, live_VBP in_IN a_DT particular_JJ region_NN ,_, go_VBP to_TO a_DT particular_JJ doctor_NN ,_, etc._FW The_DT population_NN base_NN from_IN which_WDT each_DT comparison_NN group_NN is_VBZ derived_VBN should_MD ,_, in_IN principle_NN ,_, be_VB quite_RB similar_JJ for_IN all_DT groups_NNS ._SENT Basically_RB ,_, if_IN the_DT groups_NNS are_VBP drawn_VBN from_IN a_DT similar_JJ population_NN ,_, unmeasurable_JJ and_CC potentially_RB confounding_VBG variables_NNS are_VBP more_RBR likely_JJ to_TO be_VB equally_RB distributed_VBN between_IN groups_NNS ._SENT In_IN addition_NN ,_, the_DT measurement_NN of_IN practice_NN variations_NNS cannot_MD be_VB valid_JJ without_IN information_NN on_IN relevant_JJ "_`` initial_JJ conditions_NNS "_'' ._SENT Initial_JJ conditions_NNS are_VBP all_RB confounding_VBG factors_NNS and_CC effect_NN modifiers_NNS ,_, other_JJ than_IN the_DT treatment/practice_NN patterns_NNS ,_, that_WDT may_MD cause_VB or_CC influence_VB the_DT clinical_JJ outcomes_NNS of_IN interest_NN ._SENT These_DT factors_NNS may_MD explain_VB practice_NN variations_NNS among_IN groups_NNS that_WDT do_VBP not_RB share_VB similar_JJ initial_JJ conditions_NNS ._SENT To_TO evaluate_VB practice_NN patterns-outcomes_NNS associations_NNS ,_, potential_JJ confounders_NNS must_MD be_VB identified_VBN and_CC controlled_VBN for_IN in_IN the_DT analysis_NN ._SENT Aside_RB from_IN clinical_JJ presentation_NN and_CC severity_NN of_IN illness_NN ;_: the_DT initial_JJ conditions_NNS to_TO be_VB identified_VBN and_CC characterized_VBN as_RB completely_RB as_IN possible_JJ include_VBP physician_NN ,_, patient_NN ,_, and_CC practice_NN environment_NN factors_NNS ._SENT Measurement_NN of_IN such_JJ factors_NNS is_VBZ essential_JJ to_TO minimize_VB the_DT chance_NN of_IN a_DT systematic_JJ error_NN following_VBG confounding_VBG biases_NNS and_CC effect_NN modification_NN ._SENT Figure_NP 1_CD |_SYM Table_NP 1_CD |_SYM Initial_JJ conditions_NNS to_TO be_VB taken_VBN into_IN account_NN when_WRB making_VBG inferences_NNS about_IN practice_NN patterns-outcomes_NNS associations_NNS Identification_NN and_CC measurement_NN of_IN outcomes_NNS of_IN interest_NN |_SYM Limitations_NNS to_TO the_DT development_NN and_CC evaluation_NN of_IN practice_NN guidelines_NNS also_RB include_VBP the_DT absence_NN of_IN a_DT clear_JJ concept_NN of_IN the_DT targeted_JJ outcomes_NNS and_CC the_DT paucity_NN of_IN outcomes_NNS data_NNS to_TO support_VB these_DT guidelines_NNS ._SENT There_EX appears_VBZ to_TO be_VB only_RB a_DT weak_JJ relationship_NN between_IN the_DT purpose_NN of_IN guidelines_NNS and_CC many_JJ of_IN the_DT outcomes_NNS usually_RB measured_VBN in_IN clinical_JJ research_NN ,_, that_WDT is_VBZ ,_, the_DT source_NN of_IN evidence_NN for_IN guideline_NN development_NN (_( evidence-based_JJ )_) ._SENT The_DT initial_JJ goals_NNS of_IN establishing_VBG practice_NN guidelines_NNS --_: to_TO reduce_VB costs_NNS and_CC enhance_VB the_DT quality_NN and_CC appropriateness_NN of_IN treatment_NN --_: are_VBP ,_, in_IN fact_NN ,_, rarely_RB the_DT basis_NN for_IN guideline_NN development_NN ,_, since_IN little_JJ data_NNS is_VBZ available_JJ for_IN these_DT outcomes_NNS ._SENT To_TO some_DT degree_NN ,_, the_DT development_NN of_IN guidelines_NNS has_VBZ been_VBN driven_VBN by_IN the_DT availability_NN of_IN data_NNS on_IN clinical_JJ outcomes_NNS ,_, such_JJ as_IN morbidity_NN and_CC mortality_NN ,_, rather_RB than_IN those_DT outcomes_NNS related_VBN to_TO the_DT primary_JJ goals_NNS of_IN the_DT guidelines_NNS ._SENT The_DT evaluation_NN of_IN practice_NN guidelines_NNS |_SYM Throughout_IN the_DT development_NN of_IN practice_NN guidelines_NNS ,_, the_DT major_JJ deficiency_NN has_VBZ been_VBN the_DT lack_NN of_IN an_DT evaluative_JJ method_NN ._SENT Thus_RB ,_, we_PP suggest_VBP a_DT methodological_JJ framework_NN for_IN outcomes_NNS research_NN to_TO be_VB applied_VBN to_TO evaluate_VB practice_NN guidelines_NNS ._SENT Outcomes_NNS research_NN evaluates_VBZ practice_NN patterns_NNS as_IN they_PP occur_VBP in_IN actual_JJ clinical_JJ settings_NNS ._SENT This_DT type_NN of_IN research_NN can_MD describe_VB practice_NN patterns_NNS ,_, evaluate_VB their_PP$ divergence_NN from_IN practice_NN guidelines_NNS and_CC determine_VB the_DT effect_NN of_IN practice_NN variations_NNS on_IN outcomes_NNS ._SENT Outcomes_NNS research_NN is_VBZ necessarily_RB observational_JJ in_IN nature_NN and_CC ,_, although_IN observational_JJ studies_NNS have_VBP been_VBN used_VBN to_TO evaluate_VB health_NN care_NN interventions_NNS ,_, the_DT proposed_VBN methodological_JJ framework_NN has_VBZ yet_RB to_TO be_VB applied_VBN to_TO outcomes_NNS research_NN ._SENT Why_WRB should_MD outcomes_NNS research_NN be_VB used_VBN to_TO evaluate_VB and_CC validate_VB practice_NN guidelines_NNS ?_SENT The_DT primary_JJ goal_NN of_IN practice_NN guidelines_NNS is_VBZ the_DT consistent_JJ adherence_NN by_IN physicians_NNS to_TO practice_VB patterns_NNS that_WDT achieve_VBP the_DT "_`` best_JJS "_'' outcomes_NNS at_IN the_DT lowest_JJS cost_NN ._SENT Outcomes_NNS research_NN evaluates_VBZ practice_NN patterns_NNS as_IN they_PP occur_VBP in_IN actual_JJ clinical_JJ settings_NNS ,_, and_CC is_VBZ thus_RB the_DT logical_JJ method_NN to_TO evaluate_VB practice_NN guidelines_NNS ._SENT In_IN fact_NN ,_, outcomes_NNS research_NN and_CC practice_NN guidelines_NNS are_VBP connected_VBN through_IN concepts_NNS that_WDT relate_VBP to_TO efficacy_NN and_CC effectiveness_NN research_NN ._SENT Efficacy_NN studies_NNS ,_, which_WDT normally_RB complement_VB practice_NN guideline_NN development_NN ,_, are_VBP those_DT performed_VBN in_IN highly_RB selected_VBN groups_NNS of_IN patients_NNS to_TO investigate_VB if_IN a_DT particular_JJ intervention_NN works_NNS under_IN controlled_JJ conditions_NNS set_VBN by_IN the_DT study_NN investigators_NNS ._SENT In_IN contrast_NN ,_, outcomes_NNS research_NN evaluates_VBZ practice_NN as_IN it_PP occurs_VBZ in_IN actual_JJ clinical_JJ settings_NNS ._SENT Research_NN in_IN these_DT settings_NNS is_VBZ called_VBN effectiveness_NN research_NN because_IN the_DT investigators_NNS have_VBP limited_VBN control_NN over_IN the_DT conditions_NNS that_WDT qualify_VBP the_DT practice_NN settings_NNS ._SENT The_DT difference_NN between_IN efficacy_NN and_CC effectiveness_NN research_NN can_MD be_VB summarized_VBN as_RB follows_VBZ :_: does_VBZ it_PP work_VB at_IN all_DT (_( efficacy_NN )_) or_CC does_VBZ it_PP work_VB in_IN the_DT real_JJ world_NN (_( effectiveness_NN )_) ?_SENT Thus_RB ,_, there_EX exists_VBZ a_DT dynamic_JJ process_NN in_IN which_WDT evidence_NN from_IN both_DT effectiveness_NN and_CC efficacy_NN studies_NNS feeds_VBZ into_IN the_DT development_NN and_CC evaluation_NN of_IN practice_NN guidelines_NNS ,_, as_RB depicted_VBN in_IN Figure_NP ._SENT Figure_NP 2_CD |_SYM Relationship_NN between_IN outcomes_NNS research_NN and_CC practice_NN guidelines_NNS Relationship_NN between_IN outcomes_NNS research_NN and_CC practice_NN guidelines_NNS Most_JJS practice_NN guidelines_NNS are_VBP derived_VBN from_IN efficacy_NN studies_NNS rather_RB than_IN effectiveness_NN studies_NNS ._SENT Therefore_RB ,_, it_PP is_VBZ not_RB surprising_JJ that_IN practice_NN guidelines_NNS are_VBP not_RB fully_RB applicable_JJ in_IN actual_JJ clinical_JJ practice_NN ._SENT We_PP suggest_VBP that_IN effectiveness_NN studies_NNS be_VB used_VBN not_RB only_RB as_IN a_DT method_NN to_TO evaluate_VB practice_NN guidelines_NNS but_CC also_RB as_IN a_DT basis_NN for_IN their_PP$ development_NN ._SENT These_DT could_MD include_VB both_DT observational_JJ studies_NNS and_CC effectiveness_NN trials_NNS ._SENT Outcomes_NNS research_NN better_RBR reflects_VBZ practice_NN in_IN the_DT real_JJ world_NN and_CC may_MD make_VB guidelines_NNS more_RBR likely_JJ to_TO be_VB applied_VBN ._SENT However_RB ,_, to_TO date_VB ,_, little_JJ attention_NN has_VBZ been_VBN paid_VBN to_TO the_DT epidemiological_JJ underpinnings_NN of_IN the_DT methods_NNS used_VBN to_TO conduct_VB outcomes_NNS research_NN ._SENT We_PP will_MD first_RB propose_VB a_DT methodological_JJ framework_NN for_IN outcomes_NNS research_NN ._SENT Then_RB ,_, we_PP will_MD show_VB how_WRB it_PP can_MD be_VB used_VBN to_TO evaluate_VB practice_NN guidelines_NNS ._SENT Finally_RB ,_, we_PP will_MD address_VB the_DT limitations_NNS of_IN the_DT proposed_VBN methodological_JJ framework_NN ._SENT Generic_JJ epidemiological_JJ issues_NNS in_IN outcomes_NNS research_NN |_SYM In_IN the_DT proposed_VBN methodological_JJ framework_NN ,_, the_DT generic_JJ issues_NNS related_VBN to_TO outcomes_NNS research_NN will_MD be_VB discussed_VBN in_IN sequential_JJ order_NN ._SENT In_IN outcomes_NNS research_NN ,_, the_DT first_JJ step_NN is_VBZ to_TO identify_VB the_DT study_NN population_NN and_CC the_DT groups_NNS (_( hospitals_NNS ,_, providers_NNS ,_, regions_NNS ,_, etc._FW )_) that_WDT will_MD be_VB compared_VBN ._SENT The_DT next_JJ step_NN is_VBZ the_DT measurement_NN of_IN practice_NN patterns_NNS and_CC outcomes_NNS ._SENT After_IN groups_NNS are_VBP compared_VBN on_IN the_DT basis_NN of_IN the_DT treatment_NN they_PP receive_VBP and_CC outcomes_NNS of_IN interest_NN ,_, associations_NNS are_VBP sought_VBN between_IN practice_NN patterns_NNS and_CC the_DT various_JJ measures_NNS of_IN outcome_NN ._SENT This_DT step_NN of_IN the_DT methodological_JJ framework_NN raises_VBZ issues_NNS of_IN confounding_VBG bias_NN because_IN not_RB all_DT factors_NNS that_WDT can_MD confound_VB these_DT associations_NNS are_VBP measured_VBN and_CC controlled_VBN or_CC even_RB known_VBN ._SENT The_DT presence_NN or_CC absence_NN of_IN confounding_VBG bias_NN can_MD be_VB affected_VBN by_IN the_DT other_JJ sources_NNS of_IN bias_NN namely_RB selection_NN and_CC information_NN biases_NNS ._SENT Lastly_RB ,_, we_PP discuss_VBP the_DT issue_NN of_IN temporal_JJ trends_NNS ._SENT In_IN the_DT evaluation_NN of_IN practice_NN guidelines_NNS ,_, the_DT measurement_NN of_IN practice_NN patterns_NNS may_MD not_RB be_VB contemporaneous_JJ with_IN the_DT publication_NN of_IN practice_NN guidelines_NNS ._SENT This_DT may_MD explain_VB and_CC even_RB lead_VB to_TO the_DT frequently_RB observed_VBN discrepancy_NN between_IN the_DT actual_JJ practice_NN and_CC what_WP the_DT guidelines_NNS state_VBP that_IN it_PP should_MD be_VB ._SENT Finally_RB ,_, two_CD particularities_NNS of_IN outcomes_NNS research_NN 1_CD )_) the_DT presence_NN of_IN ecological_JJ exposures_NNS in_IN individual_JJ level_NN studies_NNS and_CC 2_CD )_) the_DT common_JJ use_NN of_IN large_JJ administrative_JJ databases_NNS are_VBP discussed_VBN ._SENT Specification_NN of_IN the_DT model_NN |_SYM Definition_NN of_IN the_DT elements_NNS of_IN the_DT proposed_VBN epidemiological_JJ model_NN for_IN outcomes_NNS research_NN |_SYM In_IN the_DT proposed_VBN model_NN for_IN outcomes_NNS research_NN designed_VBN to_TO evaluate_VB practice_NN guidelines_NNS ,_, the_DT outcome_NN of_IN interest_NN can_MD be_VB a_DT disease_NN ._SENT For_IN example_NN ,_, if_IN the_DT practice_NN patterns_NNS that_WDT are_VBP being_VBG studied_VBN pertain_VBP to_TO coronary_JJ revascularization_NN ,_, complications_NNS such_JJ as_IN mortality_NN and_CC reinfarction_NN after_IN acute_JJ myocardial_JJ infarction_NN may_MD constitute_VB the_DT outcome_NN of_IN interest_NN ._SENT Finally_RB ,_, the_DT consequences_NNS of_IN different_JJ practice_NN patterns_NNS on_IN medical_JJ resources_NNS (_( cost_NN ,_, quality_NN and_CC appropriateness_NN )_) may_MD be_VB another_DT possible_JJ outcome_NN of_IN interest_NN ._SENT Table_NP 2_CD |_SYM Epidemiological_JJ model_NN for_IN outcomes_NNS research_NN to_TO evaluate_VB practice_NN guidelines_NNS In_IN the_DT studies_NNS of_IN outcome_NN research_NN ,_, practice_NN patterns_NNS ,_, (_( which_WDT constitute_VBP the_DT exposure_NN in_IN the_DT proposed_VBN model_NN )_) ,_, range_NN from_IN the_DT use_NN of_IN medication_NN ,_, diagnostic_JJ tests_NNS and_CC therapeutic_JJ procedures_NNS to_TO the_DT length_NN of_IN hospital_NN stay_NN ,_, transfer_VB to_TO other_JJ facilities_NNS and/or_CC scheduled_VBN physicians_NNS visits_NNS ._SENT The_DT primary_JJ goal_NN of_IN outcomes_NNS research_NN is_VBZ the_DT evaluation_NN of_IN the_DT effects_NNS of_IN the_DT selected_VBN practice_NN patterns_NNS on_IN the_DT outcomes_NNS of_IN interest_NN ._SENT Consequently_RB ,_, any_DT inference_NN made_VBN about_IN this_DT association_NN must_MD be_VB evaluated_VBN as_IN a_DT function_NN of_IN the_DT potential_JJ selection_NN ,_, information_NN (_( measurement_NN error_NN )_) and_CC confounding_VBG biases_NNS ._SENT A_DT limitation_NN of_IN outcomes_NNS research_NN as_IN it_PP is_VBZ most_RBS often_RB performed_VBN is_VBZ the_DT lack_NN of_IN attention_NN given_VBN to_TO the_DT measurement_NN of_IN each_DT of_IN the_DT elements_NNS of_IN the_DT epidemiological_JJ model_NN shown_VBN in_IN Table_NP 3_CD ._SENT The_DT basis_NN of_IN the_DT proposed_VBN methodological_JJ framework_NN will_MD be_VB the_DT identification_NN of_IN generic_JJ sources_NNS of_IN potential_JJ bias_NN that_WDT relate_VBP to_TO each_DT element_NN of_IN the_DT proposed_VBN model_NN ._SENT Selection_NN bias_NN |_SYM Since_IN outcomes_NNS research_NN is_VBZ observational_JJ in_IN nature_NN ,_, the_DT choice_NN of_IN the_DT study_NN population_NN and_CC of_IN the_DT compared_VBN groups_NNS is_VBZ highly_RB susceptible_JJ to_TO selection_NN bias_NN ._SENT As_RB applied_VBN to_TO outcomes_NNS research_NN ,_, selection_NN bias_NN is_VBZ defined_VBN as_IN a_DT distortion_NN in_IN the_DT estimate_NN of_IN the_DT practice_NN patterns_NNS outcomes_NNS association_NN due_JJ to_TO the_DT way_NN that_IN subjects_NNS are_VBP selected_VBN for_IN inclusion_NN in_IN the_DT study_NN population_NN and_CC in_IN the_DT different_JJ groups_NNS to_TO be_VB compared_VBN ._SENT A_DT major_JJ consequence_NN of_IN selection_NN bias_NN is_VBZ the_DT potential_NN confounding_VBG of_IN inferences_NNS made_VBN about_IN practice_NN patterns-outcomes_NNS associations_NNS ._SENT This_DT occurs_VBZ when_WRB some_DT characteristics_NNS of_IN the_DT subjects_NNS related_VBN to_TO practice_VB patterns_NNS or_CC clinical_JJ outcomes_NNS influence_VBP the_DT selection_NN or_CC exclusion_NN of_IN individual_JJ subjects_NNS ,_, groups_NNS of_IN subjects_NNS or_CC practice_NN environments_NNS ._SENT The_DT selection_NN process_NN should_MD be_VB such_JJ that_IN patients_NNS included_VBD in_IN the_DT study_NN population_NN come_VBN from_IN the_DT same_JJ target_NN population_NN ._SENT Furthermore_RB ,_, patients_NNS or_CC study_NN members_NNS should_MD have_VB a_DT similar_JJ probability_NN of_IN being_VBG selected_VBN and_CC included_VBN in_IN the_DT actual_JJ population_NN ._SENT Inclusion_NN and_CC exclusion_NN criteria_NNS must_MD be_VB clearly_RB defined_VBN in_IN order_NN to_TO characterize_VB the_DT actual_JJ population_NN as_IN precisely_RB as_RB possible_JJ ._SENT Judging_VBG the_DT internal_JJ validity_NN of_IN a_DT study_NN is_VBZ more_RBR feasible_JJ when_WRB there_EX is_VBZ a_DT detailed_JJ account_NN of_IN how_WRB the_DT individuals_NNS were_VBD selected_VBN to_TO become_VB members_NNS of_IN the_DT actual_JJ population_NN ._SENT Finally_RB ,_, the_DT study_NN population_NN ,_, also_RB needs_VBZ to_TO be_VB carefully_RB characterized_VBN so_RB that_IN the_DT inferences_NNS derived_VBN from_IN the_DT analysis_NN of_IN the_DT study_NN population_NN can_MD be_VB evaluated_VBN for_IN both_DT internal_JJ validity_NN (_( based_VBN on_IN the_DT data_NNS analyzed_VBD in_IN the_DT study_NN )_) and_CC external_JJ validity_NN (_( the_DT extent_NN to_TO which_WDT results_NNS obtained_VBN from_IN the_DT data_NNS analyzed_VBD in_IN a_DT particular_JJ study_NN can_MD be_VB generalized_VBN to_TO populations_NNS outside_JJ of_IN the_DT study_NN )_) ._SENT Any_DT systematic_JJ differences_NNS between_IN those_DT actually_RB studied_VBN and_CC the_DT source_NN (_( target_NN )_) population_NN could_MD result_VB in_IN biased_VBN estimates_NNS of_IN the_DT impact_NN of_IN a_DT practice_NN pattern_NN on_IN a_DT clinical_JJ outcome_NN ._SENT In_IN many_JJ studies_NNS of_IN outcomes_NNS research_NN ,_, groups_NNS exposed_VBN to_TO different_JJ practice_NN patterns_NNS are_VBP compared_VBN ._SENT The_DT identification_NN of_IN such_JJ groups_NNS of_IN patients_NNS is_VBZ sought_VBN to_TO assess_VB the_DT impact_NN of_IN different_JJ practice_NN patterns_NNS on_IN various_JJ outcomes_NNS in_IN actual_JJ clinical_JJ settings_NNS and_CC ,_, as_IN previously_RB mentioned_VBN ,_, can_MD be_VB used_VBN to_TO assess_VB practice_NN guidelines_NNS ._SENT Because_IN of_IN such_JJ study_NN design_NN ,_, it_PP becomes_VBZ unclear_JJ as_RB to_TO what_WP the_DT target_NN population_NN precisely_RB is_VBZ ._SENT Is_VBZ it_PP the_DT group_NN (_( the_DT set_NN of_IN patients_NNS in_IN a_DT given_VBN environment_NN )_) or_CC is_VBZ it_PP the_DT individuals_NNS receiving_VBG the_DT various_JJ practice_NN patterns_NNS within_IN each_DT group_NN ?_SENT For_IN example_NN ,_, in_IN a_DT study_NN of_IN regional_JJ variations_NNS in_IN the_DT treatment_NN of_IN acute_JJ myocardial_JJ infarction_NN in_IN the_DT U.S._NP ,_, the_DT treatment_NN of_IN patients_NNS (_( practice_NN patterns_NNS )_) was_VBD compared_VBN across_IN different_JJ regions_NNS of_IN the_DT U.S._NP In_IN this_DT study_NN ,_, one_PP wishes_VBZ to_TO generalize_VB the_DT findings_NNS about_IN practice_NN patterns-outcomes_NNS associations_NNS to_TO all_DT individuals_NNS with_IN acute_JJ myocardial_JJ infarction_NN (_( individual_JJ level_NN )_) ._SENT One_PP also_RB wishes_VBZ to_TO generalize_VB the_DT effect_NN of_IN the_DT exposure_NN ,_, which_WDT is_VBZ in_IN this_DT case_NN practice_NN patterns_NNS ,_, to_TO those_DT prevalent_JJ in_IN a_DT given_VBN region_NN (_( ecological_JJ level_NN )_) ._SENT The_DT presence_NN of_IN these_DT two_CD levels_NNS ,_, the_DT individual_NN and_CC the_DT ecological_JJ levels_NNS ,_, introduces_VBZ an_DT added_JJ level_NN of_IN complexity_NN in_IN terms_NNS of_IN the_DT assessment_NN of_IN the_DT effect_NN of_IN the_DT exposure_NN on_IN outcome_NN ._SENT When_WRB comparing_VBG practice_NN patterns_NNS across_IN regions_NNS using_VBG individual_JJ data_NNS ,_, there_EX is_VBZ a_DT certain_JJ degree_NN of_IN correlation_NN brought_VBN about_RB by_IN the_DT clustering_VBG of_IN practice_NN patterns_NNS that_WDT needs_VBZ to_TO be_VB taken_VBN into_IN account_NN ._SENT Such_PDT a_DT correlation_NN is_VBZ very_RB difficult_JJ to_TO quantify_VB ._SENT In_IN contrast_NN ,_, when_WRB assessing_VBG the_DT effect_NN of_IN the_DT exposure_NN at_IN the_DT individual_JJ level_NN ,_, there_EX are_VBP ecological_JJ factors_NNS (_( initial_JJ conditions_NNS particular_JJ to_TO a_DT given_VBN region_NN )_) that_WDT need_VBP to_TO be_VB taken_VBN into_IN account_NN ._SENT The_DT data_NNS originating_VBG from_IN studies_NNS with_IN mixed_JJ design_NN ,_, which_WDT are_VBP often_RB the_DT design_NN of_IN outcomes_NNS research_NN studies_NNS ,_, need_VBP to_TO be_VB analyzed_VBN with_IN special_JJ attention_NN to_TO the_DT degree_NN of_IN correlation_NN between_IN the_DT individual_JJ covariates_NNS and_CC to_TO the_DT presence_NN of_IN ecological_JJ exposure_NN variables_NNS ._SENT Another_DT potential_JJ source_NN of_IN selection_NN bias_NN is_VBZ the_DT choice_NN of_IN the_DT groups_NNS to_TO be_VB compared_VBN ,_, which_WDT depends_VBZ on_IN the_DT criteria_NNS used_VBN to_TO divide_VB the_DT groups_NNS ._SENT Individuals_NNS included_VBD in_IN the_DT groups_NNS to_TO be_VB compared_VBN should_MD have_VB the_DT same_JJ probability_NN of_IN being_VBG included_VBN in_IN these_DT groups_NNS ._SENT Not_RB infrequently_RB in_IN outcomes_NNS research_NN ,_, geographic_JJ criteria_NNS (_( such_JJ as_IN country_NN ,_, regions_NNS ,_, hospitals_NNS )_) are_VBP used_VBN because_IN such_JJ criteria_NNS allow_VBP the_DT identification_NN of_IN clinically_RB comparable_JJ groups_NNS that_WDT receive_VBP very_RB different_JJ treatments_NNS ,_, whose_WP$ resulting_JJ outcomes_NNS can_MD then_RB be_VB assessed_VBN ._SENT However_RB ,_, such_PDT a_DT process_NN must_MD be_VB scrutinized_VBN for_IN the_DT possibility_NN of_IN selection_NN bias_NN other_JJ than_IN the_DT treatments_NNS that_WDT are_VBP being_VBG evaluated_VBN ._SENT Such_JJ selection_NN bias_NN would_MD make_VB groups_NNS not_RB comparable_JJ as_RB to_TO clinical_JJ and_CC other_JJ factors_NNS that_WDT could_MD affect_VB outcomes_NNS ._SENT The_DT presence_NN of_IN a_DT biased_VBN selection_NN process_NN could_MD lead_VB to_TO confounding_VBG bias_NN when_WRB practice_NN patterns-outcomes_NNS associations_NNS are_VBP assessed_VBN ._SENT Such_PDT a_DT situation_NN may_MD occur_VB when_WRB the_DT study_NN groups_NNS are_VBP not_RB comparable_JJ with_IN regard_NN to_TO some_DT characteristics_NNS of_IN the_DT subjects_NNS related_VBN to_TO practice_VB patterns_NNS or_CC clinical_JJ outcomes_NNS that_WDT influenced_VBD the_DT selection_NN or_CC exclusion_NN of_IN individual_JJ subjects_NNS ,_, groups_NNS of_IN subjects_NNS or_CC practice_NN environments_NNS ._SENT For_IN example_NN ,_, in_IN the_DT same_JJ study_NN of_IN regional_JJ variations_NNS in_IN the_DT treatment_NN of_IN acute_JJ myocardial_JJ infarction_NN ,_, census_NN regions_NNS of_IN the_DT U.S._NP were_VBD arbitrarily_RB chosen_VBN as_IN a_DT basis_NN for_IN comparison_NN ._SENT In_IN this_DT example_NN ,_, patients_NNS with_IN similar_JJ risk_NN of_IN developing_VBG the_DT outcome_NN of_IN interest_NN ,_, which_WDT is_VBZ defined_VBN here_RB as_IN a_DT complication_NN after_IN acute_JJ myocardial_JJ infarction_NN ,_, may_MD not_RB have_VB had_VBN the_DT same_JJ probability_NN of_IN being_VBG included_VBN in_IN the_DT different_JJ groups_NNS to_TO be_VB compared_VBN ._SENT Confounders_NNS may_MD then_RB bias_VB the_DT practice_NN patterns/outcomes_NNS association_NN if_IN the_DT selection_NN of_IN different_JJ risk_NN groups_NNS is_VBZ related_VBN to_TO practice_VB patterns_NNS ._SENT Selection_NN bias_NN can_MD also_RB affect_VB the_DT assessment_NN of_IN outcomes_NNS ._SENT Potential_JJ sources_NNS of_IN this_DT bias_NN include_VBP loss_NN to_TO follow-up_NN or_CC missing_JJ data_NNS ._SENT Follow-up_NN data_NNS is_VBZ difficult_JJ to_TO obtain_VB in_IN outcomes_NNS research_NN studies_NNS ,_, which_WDT often_RB rely_VBP on_IN administrative_JJ databases_NNS for_IN data_NN acquisition_NN ._SENT Linkage_NN ,_, either_CC of_IN different_JJ databases_NNS or_CC of_IN the_DT same_JJ database_NN over_IN time_NN ,_, is_VBZ often_RB performed_VBN ._SENT A_DT failure_NN to_TO link_VB the_DT databases_NNS for_IN a_DT number_NN of_IN individuals_NNS presents_VBZ a_DT problem_NN equivalent_NN to_TO having_VBG data_NNS missing_VBG for_IN these_DT individuals_NNS ._SENT Information_NN bias_NN |_SYM The_DT second_JJ step_NN in_IN outcomes_NNS research_NN studies_NNS is_VBZ the_DT measurement_NN of_IN practice_NN patterns_NNS and_CC of_IN the_DT outcomes_NNS of_IN interest_NN ._SENT Here_RB ,_, issues_NNS of_IN information_NN bias_NN must_MD be_VB considered_VBN ._SENT Information_NN bias_NN can_MD be_VB defined_VBN as_IN a_DT distortion_NN of_IN the_DT potential_JJ practice_NN patterns_NNS outcomes_NNS association_NN due_JJ to_TO misclassification_NN of_IN subjects_NNS with_IN regard_NN to_TO practice_NN patterns_NNS ,_, outcome_NN measures_NNS or_CC both_DT ,_, or_CC due_JJ to_TO measurement_NN error_NN ._SENT There_EX are_VBP two_CD major_JJ ways_NNS in_IN which_WDT practice_NN patterns_NNS can_MD be_VB misclassified_VBN ._SENT They_PP relate_VBP to_TO the_DT sensitivity_NN and_CC specificity_NN of_IN the_DT tests_NNS that_WDT are_VBP used_VBN for_IN the_DT diagnosis_NN for_IN which_WDT practice_NN patterns_NNS are_VBP being_VBG evaluated_VBN and_CC for_IN the_DT classification_NN of_IN the_DT outcomes_NNS of_IN interest_NN ._SENT The_DT measurement_NN of_IN the_DT different_JJ practice_NN patterns_NNS and_CC their_PP$ related_JJ outcomes_NNS largely_RB depend_VBP on_IN the_DT identification_NN of_IN a_DT group_NN of_IN patients_NNS who_WP have_VBP a_DT given_VBN diagnosis_NN and_CC require_VB a_DT given_VBN treatment_NN ._SENT The_DT characteristics_NNS that_WDT make_VBP a_DT diagnosis_NN more_RBR amenable_JJ to_TO outcomes_NNS research_NN are_VBP the_DT following_VBG :_: 1_LS )_) a_DT precise_JJ diagnostic_JJ definition_NN ,_, 2_LS )_) a_DT diagnostic_JJ test_NN with_IN high_JJ sensitivity_NN and_CC specificity_NN ,_, 3_CD )_) reproducibility_NN among_IN different_JJ individuals_NNS and_CC locations_NNS ,_, 4_LS )_) easily_RB coded_VBN ,_, 5_LS )_) related_VBN to_TO a_DT procedure_NN ,_, and_CC 6_CD )_) common_JJ and_CC costly_JJ ,_, so_RB that_IN it_PP is_VBZ likely_JJ to_TO be_VB collected_VBN in_IN large_JJ ,_, administrative_JJ databases_NNS frequently_RB used_VBN in_IN outcomes_NNS research_NN ._SENT Because_IN of_IN such_JJ requirements_NNS ,_, only_RB a_DT limited_JJ number_NN of_IN clinical_JJ conditions_NNS are_VBP amenable_JJ to_TO outcomes_NNS research_NN ._SENT Acute_JJ myocardial_JJ infarction_NN is_VBZ an_DT example_NN of_IN a_DT diagnosis_NN that_WDT can_MD be_VB made_VBN with_IN a_DT high_JJ level_NN of_IN certainty_NN because_IN it_PP has_VBZ a_DT precise_JJ diagnostic_JJ definition_NN and_CC well-defined_JJ diagnostic_JJ criteria_NNS ,_, which_WDT ,_, when_WRB taken_VBN together_RB ,_, have_VBP high_JJ sensitivity_NN and_CC specificity_NN for_IN the_DT correct_JJ classification_NN of_IN patients_NNS ._SENT Therefore_RB ,_, it_PP is_VBZ easy_JJ to_TO identify_VB a_DT study_NN population_NN that_IN ,_, in_IN fact_NN ,_, has_VBZ this_DT disease_NN and_CC to_TO describe_VB their_PP$ treatment_NN ._SENT Thus_RB ,_, in_IN order_NN to_TO minimize_VB the_DT misclassification_NN of_IN relevant_JJ practice_NN patterns_NNS ,_, the_DT methods_NNS used_VBN to_TO classify_VB the_DT disease_NN and_CC the_DT outcomes_NNS that_WDT relate_VBP to_TO the_DT practice_NN patterns_NNS under_IN investigation_NN must_MD have_VB high_JJ sensitivity_NN and_CC specificity_NN ._SENT Given_VBN the_DT principles_NNS underlying_VBG the_DT measurement_NN of_IN practice_NN patterns_NNS and_CC outcomes_NNS ,_, how_WRB are_VBP the_DT measurements_NNS generally_RB made_VBN in_IN outcomes_NNS research_NN studies_NNS ?_SENT The_DT measurement_NN of_IN the_DT exposure_NN (_( practice_NN patterns_NNS )_) in_IN outcomes_NNS research_NN is_VBZ valid_JJ only_RB if_IN it_PP corresponds_VBZ to_TO the_DT "_`` true_JJ "_'' practice_NN as_IN performed_VBN in_IN the_DT clinical_JJ setting_NN ._SENT Again_RB ,_, practice_NN can_MD only_RB be_VB "_`` true_JJ "_'' if_IN the_DT diagnosis_NN is_VBZ correct_JJ ._SENT The_DT identification_NN of_IN both_DT patients_NNS with_IN the_DT disease_NN of_IN interest_NN and_CC their_PP$ treatment_NN requires_VBZ a_DT source_NN of_IN information_NN that_WDT has_VBZ the_DT features_NNS of_IN a_DT diagnostic_JJ test_NN ._SENT In_IN outcomes_NNS research_NN ,_, administrative_JJ databases_NNS are_VBP often_RB used_VBN as_IN an_DT information_NN source_NN to_TO identify_VB a_DT study_NN population_NN and_CC to_TO obtain_VB data_NNS on_IN exposure_NN ._SENT The_DT database_NN coding_VBG of_IN diagnoses_NNS and_CC procedures_NNS can_MD be_VB used_VBN as_IN a_DT "_`` diagnostic_JJ test_NN "_'' to_TO identify_VB the_DT clinical_JJ condition_NN for_IN which_WDT practice_NN patterns_NNS will_MD be_VB described_VBN and_CC to_TO classify_VB the_DT practice_NN patterns_NNS themselves_PP and_CC the_DT outcomes_NNS of_IN interest_NN ._SENT Such_PDT a_DT "_`` diagnostic_JJ test_NN "_'' will_MD have_VB higher_JJR sensitivity_NN and_CC specificity_NN values_NNS for_IN some_DT diagnoses_NNS than_IN for_IN others_NNS ._SENT For_IN example_NN ,_, administrative_JJ database_NN coding_VBG will_MD have_VB higher_JJR sensitivity_NN and_CC specificity_NN for_IN procedure-related_JJ diagnoses_NNS (_( such_JJ as_IN hip_JJ fracture_NN )_) because_IN the_DT diagnostic_JJ code_NN is_VBZ related_VBN to_TO a_DT major_JJ operation_NN and_CC is_VBZ likely_JJ to_TO be_VB recorded_VBN for_IN administrative_JJ purposes_NNS ._SENT In_IN contrast_NN ,_, a_DT diagnostic_JJ criterion_NN for_IN osteoarthritis_NN can_MD be_VB quite_RB vague_JJ and_CC administrative_JJ coding_VBG is_VBZ likely_JJ to_TO have_VB very_RB low_JJ sensitivity_NN and_CC specificity_NN for_IN this_DT diagnosis_NN ._SENT The_DT use_NN of_IN databases_NNS as_IN a_DT diagnostic_JJ test_NN must_MD be_VB validated_VBN in_IN all_DT outcomes_NNS research_NN studies_NNS ,_, especially_RB those_DT using_VBG administrative_JJ databases_NNS ._SENT Methods_NNS to_TO validate_VB these_DT databases_NNS include_VBP chart_NN reviews_NNS ,_, a_DT priori_NN coding_VBG systems_NNS or_CC both_DT ._SENT These_DT validation_NN methods_NNS ensure_VBP that_IN coding_VBG is_VBZ as_RB accurate_JJ and_CC reproducible_JJ as_IN possible_JJ ,_, thus_RB allowing_VBG the_DT database_NN to_TO be_VB used_VBN as_IN a_DT diagnostic_JJ test_NN to_TO identify_VB the_DT study_NN population_NN and_CC the_DT practice_NN patterns_NNS and_CC the_DT outcomes_NNS in_IN outcomes_NNS research_NN ._SENT However_RB ,_, these_DT validation_NN methods_NNS are_VBP rarely_RB used_VBN ._SENT Finally_RB ,_, appropriate_JJ measures_NNS of_IN outcomes_NNS that_WDT will_MD serve_VB to_TO evaluate_VB practice_NN guidelines_NNS must_MD be_VB identified_VBN ._SENT This_DT presents_VBZ a_DT problem_NN because_IN most_JJS practice_NN guidelines_NNS aim_VBP to_TO reduce_VB practice_NN variations_NNS ,_, which_WDT will_MD ,_, in_IN turn_NN ,_, lead_VBP to_TO improved_VBN appropriateness_NN and_CC quality_NN of_IN care_NN ._SENT However_RB ,_, how_WRB appropriateness_NN and_CC quality_NN of_IN care_NN are_VBP measured_VBN is_VBZ controversial_JJ and_CC will_MD not_RB be_VB discussed_VBN here_RB ._SENT Nevertheless_RB ,_, defining_VBG the_DT outcomes_NNS that_WDT will_MD be_VB used_VBN to_TO evaluate_VB practice_NN guidelines_NNS is_VBZ a_DT crucial_JJ step_NN in_IN this_DT process_NN ._SENT Quality_NN of_IN life_NN and_CC functional_JJ status_NN measures_NNS constitute_VBP another_DT group_NN of_IN outcome_NN measures_NNS that_WDT should_MD be_VB included_VBN for_IN the_DT evaluation_NN of_IN practice_NN guidelines_NNS ._SENT These_DT dimensions_NNS of_IN outcomes_NNS have_VBP received_VBN more_JJR attention_NN from_IN health_NN providers_NNS ,_, while_IN consumers_NNS have_VBP become_VBN more_RBR concerned_JJ about_IN outcomes_NNS of_IN care_NN ._SENT However_RB ,_, these_DT outcomes_NNS also_RB are_VBP difficult_JJ to_TO measure_VB ,_, because_IN they_PP rely_VBP heavily_RB on_IN patient_JJ interviews_NNS and_CC questionnaires_NNS ._SENT They_PP are_VBP likely_JJ to_TO vary_VB with_IN patient_JJ expectations_NNS ,_, culture_NN ,_, and_CC climate_NN and_CC are_VBP thus_RB potentially_RB to_TO be_VB measured_VBN with_IN error_NN and_CC be_VB misclassified_VBN ._SENT A_DT few_JJ reliable_JJ ,_, valid_JJ instruments_NNS have_VBP been_VBN developed_VBN to_TO assess_VB health-related_JJ quality_NN of_IN life_NN ,_, but_CC such_JJ instruments_NNS are_VBP not_RB easily_RB used_VBN to_TO collect_VB this_DT information_NN from_IN large_JJ databases_NNS ._SENT There_EX is_VBZ a_DT need_NN to_TO develop_VB instruments_NNS to_TO measure_VB these_DT types_NNS of_IN outcomes_NNS ,_, whether_IN they_PP are_VBP conversion_NN factors_NNS for_IN existing_JJ databases_NNS (_( such_JJ using_VBG length_NN of_IN stay_NN as_IN a_DT proxy_NN for_IN cost_NN )_) or_CC new_JJ measures_NNS that_WDT could_MD easily_RB be_VB integrated_VBN in_IN administrative_JJ databases_NNS ._SENT Such_JJ measures_NNS could_MD include_VB estimates_NNS of_IN functional_JJ class_NN or_CC severity_NN of_IN illness_NN ._SENT At_IN present_JJ ,_, many_JJ outcomes_NNS research_NN studies_NNS measure_NN mortality_NN and_CC disease-specific_JJ morbidity_NN ._SENT The_DT validity_NN of_IN the_DT measurement_NN of_IN these_DT outcomes_NNS is_VBZ limited_VBN by_IN the_DT type_NN of_IN database_NN that_WDT is_VBZ used_VBN ._SENT For_IN example_NN ,_, using_VBG death_NN registries_NNS to_TO obtain_VB causes_NNS for_IN death_NN is_VBZ a_DT notoriously_RB invalid_JJ source_NN for_IN this_DT type_NN of_IN information_NN ._SENT There_EX are_VBP many_JJ examples_NNS of_IN poor_JJ correlation_NN between_IN cause_NN of_IN death_NN as_IN established_VBN by_IN death_NN registries_NNS versus_CC disease_NN registries_NNS ._SENT Death_NN certificates_NNS in_IN New_NP York_NP City_NP during_IN 1992_CD were_VBD assessed_VBN to_TO determine_VB the_DT accuracy_NN and_CC frequency_NN of_IN reporting_VBG tuberculosis_NN as_IN a_DT cause_NN of_IN death_NN ._SENT Of_IN 310_CD persons_NNS who_WP died_VBD with_IN active_JJ tuberculosis_NN in_IN 1992_CD (_( based_VBN on_IN a_DT disease-specific_JJ registry_NN )_) ,_, only_RB 34_CD %_NN had_VBD tuberculosis_NN listed_VBN on_IN their_PP$ death_NN certificate_NN ._SENT Thus_RB ,_, in_IN this_DT example_NN ,_, as_RB in_IN many_JJ others_NNS like_IN it_PP ,_, using_VBG death_NN certificates_NNS led_VBD to_TO an_DT inaccurate_JJ measure_NN of_IN disease_NN burden_NN ._SENT Confounding_VBG bias_NN |_SYM In_IN outcomes_NNS research_NN terms_NNS ,_, confounding_VBG bias_NN is_VBZ present_JJ when_WRB the_DT effect_NN of_IN the_DT practice_NN variations_NNS on_IN the_DT outcomes_NNS of_IN interest_NN is_VBZ distorted_VBN because_IN of_IN the_DT effects_NNS of_IN extraneous_JJ variables_NNS (_( variables_NNS that_WDT are_VBP causally_RB associated_VBN with_IN the_DT practice_NN variations_NNS and_CC the_DT outcomes_NNS of_IN interest_NN )_) ._SENT This_DT issue_NN is_VBZ crucial_JJ in_IN outcomes_NNS research_NN because_IN ,_, while_IN outcomes_NNS research_NN shares_NNS the_DT purpose_NN of_IN a_DT clinical_JJ trial_NN (_( to_TO evaluate_VB different_JJ treatments_NNS )_) ,_, it_PP primarily_RB uses_VBZ observational_JJ methods_NNS --_: investigators_NNS conducting_VBG outcomes_NNS research_NN have_VBP limited_VBN control_NN over_IN potentially_RB confounding_VBG factors_NNS (_( the_DT initial_JJ conditions_NNS of_IN individual_JJ groups_NNS of_IN patients_NNS )_) ._SENT Because_IN outcomes_NNS research_NN builds_VBZ on_IN existing_VBG practice_NN variations_NNS and_CC analyses_VBZ the_DT natural_JJ ongoing_JJ experiment_NN ,_, there_EX is_VBZ ample_JJ opportunity_NN for_IN confounding_VBG bias_NN to_TO invalidate_VB any_DT inference_NN made_VBN about_IN practice_NN patterns_NNS outcome_NN associations_NNS ._SENT For_IN example_NN ,_, variations_NNS in_IN practice_NN patterns_NNS could_MD reflect_VB variation_NN not_RB only_RB in_IN the_DT use_NN of_IN a_DT given_VBN procedure_NN but_CC also_RB in_IN the_DT severity_NN of_IN disease_NN ._SENT Assignment_NN of_IN patients_NNS to_TO certain_JJ procedures_NNS on_IN the_DT basis_NN of_IN the_DT severity_NN of_IN illness_NN makes_VBZ sense_NN clinically_RB ,_, but_CC in_IN outcomes_NNS research_NN ,_, it_PP is_VBZ a_DT common_JJ and_CC important_JJ source_NN of_IN confounding_VBG if_IN the_DT procedure_NN is_VBZ either_RB efficacious_JJ or_CC particularly_RB harmful_JJ in_IN high-risk_JJ patients_NNS ._SENT Many_JJ indices_NN have_VBP been_VBN developed_VBN to_TO measure_VB the_DT severity_NN of_IN illness_NN when_WRB using_VBG existing_VBG databases_NNS to_TO correct_VB for_IN such_JJ confounding_VBG ,_, but_CC one_PP can_MD never_RB be_VB sure_JJ that_IN this_DT type_NN of_IN confounding_VBG has_VBZ been_VBN entirely_RB controlled_VBN ._SENT This_DT presents_VBZ an_DT intrinsic_JJ limitation_NN of_IN outcomes_NNS research_NN ._SENT Avoidance_NN of_IN confounding_VBG bias_NN is_VBZ limited_VBN by_IN the_DT source_NN of_IN data_NNS used_VBN to_TO describe_VB practice_NN patterns_NNS ,_, particularly_RB when_WRB observational_JJ data_NNS ,_, such_JJ as_IN the_DT large_JJ Medicare_NP administrative_JJ databases_NNS ,_, are_VBP used_VBN to_TO compare_VB outcomes_NNS among_IN patients_NNS who_WP receive_VBP different_JJ treatments_NNS ._SENT The_DT potential_NN for_IN confounding_VBG bias_NN arises_VBZ because_IN many_JJ factors_NNS other_JJ than_IN the_DT treatment_NN under_IN evaluation_NN may_MD affect_VB patient_JJ outcomes_NNS ._SENT These_DT factors_NNS include_VBP comorbid_JJ diseases_NNS ,_, severity_NN of_IN illness_NN ,_, and_CC patient_NN ,_, physician_NN and_CC environmental_JJ factors_NNS ._SENT Such_JJ factors_NNS are_VBP likely_JJ to_TO influence_VB treatment_NN decisions_NNS but_CC are_VBP difficult_JJ to_TO capture_VB fully_RB in_IN recorded_JJ data_NNS ._SENT Researchers_NNS cannot_MD adjust_VB for_IN imbalances_NNS in_IN prognostic_JJ factors_NNS that_WDT are_VBP unmeasured_JJ or_CC poorly_RB categorized_VBN and_CC administrative_JJ data_NNS ,_, in_IN particular_JJ ,_, may_MD lack_VB the_DT precise_JJ and_CC accurate_JJ coverage_NN of_IN clinical_JJ details_NNS needed_VBN to_TO permit_VB full_JJ and_CC fair_JJ adjustments_NNS ._SENT Further_JJR data_NNS collection_NN might_MD solve_VB this_DT issue_NN ,_, but_CC it_PP is_VBZ not_RB always_RB possible_JJ to_TO collect_VB additional_JJ information_NN ._SENT Standard_JJ statistical_JJ modeling_NN can_MD attempt_VB to_TO adjust_VB for_IN the_DT known_VBN differences_NNS between_IN the_DT groups_NNS ,_, but_CC this_DT might_MD not_RB be_VB sufficient_JJ for_IN unmeasured_JJ differences_NNS ._SENT Several_JJ alternative_JJ methods_NNS have_VBP been_VBN suggested_VBN ._SENT One_CD method_NN is_VBZ subgroup_NN analysis_NN to_TO adjust_VB for_IN unmeasured_JJ differences_NNS between_IN groups_NNS of_IN individuals_NNS who_WP differ_VBP on_IN known_VBN risk_NN factors_NNS ._SENT Another_DT method_NN consists_VBZ of_IN the_DT use_NN of_IN instrumental_JJ variables_NNS ._SENT Instrumental_JJ variables_NNS are_VBP observable_JJ factors_NNS that_WDT influence_VBP treatments_NNS but_CC do_VBP not_RB directly_RB affect_VB patient_JJ outcomes_NNS ._SENT This_DT approach_NN uses_VBZ the_DT so-called_JJ instrumental_JJ variables_NNS to_TO mimic_VB a_DT randomization_NN of_IN patients_NNS to_TO different_JJ likelihoods_NNS of_IN receiving_VBG alternative_JJ treatments_NNS ._SENT McClellan_NP et_FW al._FW applied_VBD this_DT methodology_NN to_TO assess_VB whether_IN more_JJR aggressive_JJ use_NN of_IN invasive_JJ cardiac_JJ procedures_NNS improved_VBD outcomes_NNS in_IN the_DT elderly_JJ ._SENT In_IN this_DT study_NN ,_, the_DT instrumental_JJ variable_NN was_VBD the_DT distance_NN of_IN the_DT patient_NN 's_POS residence_NN from_IN the_DT nearest_JJS hospital_NN with_IN on-site_JJ angiography_NN ._SENT The_DT authors_NNS noted_VBD lower_JJR mortality_NN among_IN elderly_JJ individuals_NNS who_WP received_VBD more_RBR aggressive_JJ treatment_NN than_IN among_IN those_DT treated_VBN more_RBR conservatively_RB ._SENT Temporal_JJ trend_JJ bias_NN |_SYM We_PP propose_VBP a_DT bias_NN called_VBD a_DT "_`` temporal_JJ trend_NN bias_NN "_'' that_WDT is_VBZ particular_JJ to_TO the_DT use_NN of_IN outcomes_NNS research_NN to_TO evaluate_VB practice_NN guidelines_NNS ._SENT This_DT bias_NN results_NNS from_IN the_DT inability_NN to_TO control_VB for_IN secular_JJ trends_NNS ._SENT It_PP reflects_VBZ the_DT fact_NN that_IN by_IN the_DT time_NN practice_NN guidelines_NNS are_VBP published_VBN and_CC disseminated_VBN ,_, new_JJ treatments_NNS and_CC technology_NN are_VBP being_VBG incorporated_VBN into_IN clinical_JJ practice_NN ._SENT Thus_RB ,_, it_PP is_VBZ difficult_JJ to_TO identify_VB a_DT pure_JJ application_NN of_IN a_DT practice_NN guideline_NN whose_WP$ application_NN is_VBZ not_RB undermined_VBN by_IN recent_JJ advances_NNS in_IN medicine_NN and_CC technology_NN ._SENT For_IN example_NN ,_, we_PP evaluated_VBD the_DT effect_NN of_IN a_DT specific_JJ set_NN of_IN guidelines_NNS on_IN return_NN to_TO work_VB after_IN acute_JJ myocardial_JJ infarction_NN ._SENT The_DT use_NN of_IN these_DT guidelines_NNS had_VBD been_VBN successful_JJ in_IN a_DT university_NN setting_NN ;_: this_DT study_NN assessed_VBD their_PP$ use_NN in_IN a_DT community_NN setting_NN ._SENT During_IN the_DT 5_CD years_NNS that_WDT elapsed_VBD between_IN these_DT two_CD studies_NNS ,_, practices_NNS changed_VBD ._SENT The_DT use_NN of_IN guidelines_NNS was_VBD less_RBR successful_JJ in_IN the_DT community_NN not_RB only_RB because_IN they_PP did_VBD not_RB influence_VB practice_NN but_CC also_RB because_IN usual_JJ care_NN had_VBD grown_VBN closer_RBR to_TO the_DT proposed_VBN guidelines_NNS ._SENT Ecological_JJ exposure_NN in_IN individual_JJ level_JJ studies_NNS |_SYM A_DT frequently_RB encountered_VBN particularity_NN of_IN outcomes_NNS research_NN study_NN design_NN is_VBZ the_DT presence_NN of_IN both_DT ecological_JJ exposure_NN and_CC individual_JJ level_NN covariates_NNS in_IN the_DT same_JJ analysis_NN ._SENT Because_IN the_DT unit_NN of_IN analysis_NN is_VBZ a_DT group_NN ,_, but_CC inferences_NNS are_VBP made_VBN about_IN the_DT impact_NN of_IN a_DT given_VBN practice_NN pattern_NN on_IN individual_JJ outcomes_NNS ,_, many_JJ outcomes_NNS research_NN analyses_NNS have_VBP elements_NNS of_IN both_DT individual_JJ and_CC ecological_JJ analyses_NNS ._SENT In_IN our_PP$ study_NN of_IN regional_JJ variations_NNS in_IN the_DT treatment_NN of_IN acute_JJ myocardial_JJ infarction_NN ,_, measures_NNS describing_VBG practice_NN patterns_NNS at_IN the_DT regional_JJ level_NN ,_, ecological_JJ exposure_NN ,_, (_( proportion_NN of_IN patients_NNS receiving_VBG angiography_NN ,_, angioplasty_JJ ,_, and_CC coronary_JJ artery_NN bypass_NN surgery_NN )_) were_VBD linked_VBN to_TO the_DT outcome_NN measures_NNS of_IN mortality_NN adjusting_VBG for_IN individual_JJ level_NN variables_NNS that_WDT measured_VBD severity_NN of_IN disease_NN ._SENT Then_RB ,_, inferences_NNS were_VBD made_VBN about_IN the_DT use_NN of_IN these_DT procedures_NNS at_IN the_DT patient_JJ level_NN ._SENT Although_IN the_DT unit_NN of_IN analysis_NN is_VBZ the_DT region_NN ,_, which_WDT would_MD demand_VB an_DT ecological_JJ analysis_NN ,_, there_EX are_VBP individual_JJ level_NN covariates_NNS ,_, which_WDT are_VBP likely_JJ to_TO be_VB correlated_VBN within_IN each_DT region_NN ,_, that_WDT need_VBP to_TO be_VB taken_VBN into_IN account_NN ._SENT When_WRB group_NN measures_NNS are_VBP used_VBN that_DT contain_VBP individual-level_JJ variability_NN with_IN some_DT degree_NN of_IN correlatedness_NN (_( within_IN region_NN )_) and_CC aggregate-level_JJ variability_NN (_( between_IN regions_NNS )_) ,_, specific_JJ analytic_JJ tools_NNS must_MD be_VB used_VBN ._SENT It_PP has_VBZ been_VBN suggested_VBN that_IN hierarchical_JJ logistic_JJ regression_NN modeling_NN be_VB used_VBN to_TO examine_VB the_DT interplay_NN between_IN sources_NNS of_IN variation_NN in_IN the_DT use_NN of_IN health-care_JJ services_NNS ,_, that_WDT is_VBZ ,_, between_IN ecological-level_JJ and_CC individual-level_JJ sources_NNS ._SENT This_DT type_NN of_IN modeling_NN is_VBZ designed_VBN to_TO separate_VB true_JJ variability_NN across_IN areas_NNS from_IN observed_JJ variability_NN ._SENT An_DT application_NN of_IN this_DT method_NN is_VBZ the_DT work_NN by_IN Gatsonis_NP et_FW al._FW who_WP found_VBD that_IN practice_NN variations_NNS across_IN regions_NNS of_IN the_DT U.S._NP in_IN the_DT use_NN of_IN angiography_NN after_IN acute_JJ myocardial_JJ infarction_NN were_VBD largely_RB explained_VBN by_IN differences_NNS in_IN patient_JJ characteristics_NNS and_CC geographic_JJ region_NN ._SENT However_RB ,_, states_NNS that_WDT had_VBD more_RBR on-site_JJ availability_NN of_IN angiography_NN still_RB tended_VBD to_TO have_VB higher_JJR angiography_NN rates_NNS after_IN accounting_NN for_IN between-region_NN and_CC within-region_NN variability_NN ._SENT After_IN analysis_NN for_IN sources_NNS of_IN variability_NN ,_, more_JJR reliable_JJ inferences_NNS about_IN the_DT associations_NNS between_IN practice_NN patterns_NNS and_CC outcomes_NNS can_MD be_VB made_VBN ._SENT Sources_NNS of_IN data_NNS |_SYM The_DT application_NN of_IN the_DT proposed_VBN methodological_JJ framework_NN for_IN outcomes_NNS resear_JJ 